{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T20:04:53Z","timestamp":1784750693651,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,10,26]],"date-time":"2016-10-26T00:00:00Z","timestamp":1477440000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s40257-016-0231-3","type":"journal-article","created":{"date-parts":[[2016,10,26]],"date-time":"2016-10-26T11:00:27Z","timestamp":1477479627000},"page":"701-707","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Deoxycholic Acid: A Review in Submental Fat Contouring"],"prefix":"10.1007","volume":"17","author":[{"given":"Emma D.","family":"Deeks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,26]]},"reference":[{"key":"231_CR1","unstructured":"Kythera Biopharmaceuticals Inc. ATX-101 (deoxycholic acid) injection: Advisory Committee Briefing Materials: available for public release. 2015. http:\/\/www.accessdata.fda.gov\/scripts\/cder\/drugsatfda\/ . Accessed 17 Oct 2016."},{"issue":"2","key":"231_CR2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2147\/ciia.2006.1.2.115","volume":"1","author":"R Honigman","year":"2006","unstructured":"Honigman R, Castle DJ. Aging and cosmetic enhancement. Clin Interv Aging. 2006;1(2):115\u20139.","journal-title":"Clin Interv Aging."},{"issue":"1","key":"231_CR3","first-page":"27","volume":"11","author":"J Schlessinger","year":"2013","unstructured":"Schlessinger J, Weiss SR, Jewell M, et al. Perceptions and practices in submental fat treatment: a survey of physicians and patients. Skinmed. 2013;11(1):27\u201331.","journal-title":"Skinmed."},{"key":"231_CR4","doi-asserted-by":"crossref","unstructured":"Koehler J. Complications of neck liposuction and submentoplasty. Oral Maxillofac Surg Clin North Am. 2009;21(1):43\u201352, vi.","DOI":"10.1016\/j.coms.2008.10.008"},{"issue":"4","key":"231_CR5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/01676830601034532","volume":"25","author":"BC Patel","year":"2006","unstructured":"Patel BC. Aesthetic surgery of the aging neck: options and techniques. Orbit. 2006;25(4):327\u201356.","journal-title":"Orbit."},{"key":"231_CR6","unstructured":"Petrou I. Minimally invasive submental fat reduction proves successful. 2011. http:\/\/cosmeticsurgerytimes.modernmedicine.com . Accessed 17 Oct 2016."},{"issue":"7","key":"231_CR7","first-page":"1001","volume":"30","author":"AM Rotunda","year":"2004","unstructured":"Rotunda AM, Suzuki H, Moy RL, et al. Detergent effects of sodium deoxycholate are a major feature of an injectable phosphatidylcholine formulation used for localized fat dissolution. Dermatol Surg. 2004;30(7):1001\u20138.","journal-title":"Dermatol Surg."},{"issue":"5","key":"231_CR8","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2013.03.013","volume":"17","author":"TQ Aguiar Vallim de","year":"2013","unstructured":"de Aguiar Vallim TQ, Tarling EJ, Edwards PA. Pleiotropic roles of bile acids in metabolism. Cell Metab. 2013;17(5):657\u201369.","journal-title":"Cell Metab."},{"key":"231_CR9","unstructured":"Kythera Biopharmaceuticals Inc. Kybella\u2122 (deoxycholic acid) injection, for subcutaneous use: US prescribing information. 2015. http:\/\/www.accessdata.fda.gov\/scripts\/cder\/drugsatfda\/ . Accessed 17 Oct 2016."},{"key":"231_CR10","unstructured":"Kythera Biopharmaceuticals (Europe) Ltd. Belkyra 10\u00a0mg\/ml solution for injection: EU summary of product characteristics. 2016. http:\/\/mri.medagencies.org\/Human\/Product\/Details\/48055 . Accessed 17 Oct 2016."},{"issue":"6","key":"231_CR11","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1524-4725.2010.01566.x","volume":"36","author":"R Thuangtong","year":"2010","unstructured":"Thuangtong R, Bentow JJ, Knopp K, et al. Tissue-selective effects of injected deoxycholate. Dermatol Surg. 2010;36(6):899\u2013908.","journal-title":"Dermatol Surg."},{"key":"231_CR12","doi-asserted-by":"crossref","unstructured":"Dover J, Schlessinger J, Young L, et al. Reduction of submental fat with ATX-101: results from a phase IIB study using investigator, subject, and magnetic resonance imaging assessments [abstract no. 4787]. J Am Acad Dermatol. 2012;66(4 Suppl. 1):AB29.","DOI":"10.1016\/j.jaad.2011.11.128"},{"key":"231_CR13","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1365-2133.2011.10313.x","volume":"165","author":"S Ogden","year":"2011","unstructured":"Ogden S, Griffiths T. A novel injectable drug for the reduction of localized fat. Br J Dermatol. 2011;165:98\u20139.","journal-title":"Br J Dermatol."},{"issue":"2","key":"231_CR14","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/bjd.12695","volume":"170","author":"B Rzany","year":"2014","unstructured":"Rzany B, Griffiths T, Walker P, et al. Reduction of unwanted submental fat with ATX-101 (deoxycholic acid), an adipocytolytic injectable treatment: results from a phase III, randomized, placebo-controlled study. Br J Dermatol. 2014;170(2):445\u201353.","journal-title":"Br J Dermatol."},{"issue":"12","key":"231_CR15","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/jdv.12377","volume":"28","author":"B Ascher","year":"2014","unstructured":"Ascher B, Hoffmann K, Walker P, et al. Efficacy, patient-reported outcomes and safety profile of ATX-101 (deoxycholic acid), an injectable drug for the reduction of unwanted submental fat: results from a phase III, randomized, placebo-controlled study. J Eur Acad Dermatol Venereol. 2014;28(12):1707\u201315.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"1","key":"231_CR16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/jocd.12122","volume":"14","author":"P Walker","year":"2015","unstructured":"Walker P, Lee D. A phase 1 pharmacokinetic study of ATX-101: serum lipids and adipokines following synthetic deoxycholic acid injections. J Cosmet Dermatol. 2015;14(1):33\u20139.","journal-title":"J Cosmet Dermatol."},{"issue":"3","key":"231_CR17","first-page":"279","volume":"14","author":"P Walker","year":"2015","unstructured":"Walker P, Fellmann J, Lizzul PF. A phase I safety and pharmacokinetic study of ATX-101: injectable, synthetic deoxycholic acid for submental contouring. J Drugs Dermatol. 2015;14(3):279\u201387.","journal-title":"J Drugs Dermatol."},{"issue":"1","key":"231_CR18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/DSS.0000000000000578","volume":"42","author":"DH Jones","year":"2016","unstructured":"Jones DH, Carruthers J, Joseph JH, et al. REFINE-1, a multicenter, randomized, double-blind, placebo-controlled, phase 3 trial with ATX-101, an injectable drug for submental fat reduction. Dermatol Surg. 2016;42(1):38\u201349.","journal-title":"Dermatol Surg."},{"issue":"4","key":"231_CR19","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.jaad.2016.04.028","volume":"75","author":"S Humphrey","year":"2016","unstructured":"Humphrey S, Sykes J, Kantor J, et al. ATX-101 for reduction of submental fat: a phase III randomized controlled trial. J Am Acad Dermatol. 2016;75(4):788\u201397.","journal-title":"J Am Acad Dermatol."},{"key":"231_CR20","unstructured":"US National Institutes of Health. ClinicalTrials.gov identifiers NCT01542034 and NCT01546142. 2014. http:\/\/www.clinicaltrials.gov . Accessed 15 Aug 2016."},{"key":"231_CR21","unstructured":"Bhatia AC, Dayan SH, Hoffmann K, et al. Reductions in submental fat achieved with deoxycholic acid injection (ATX-101) are maintained over time: results from long-term, follow-up studies [abstract]. In: American Society for Dermatologic Surgery Annual Meeting; 2015."},{"key":"231_CR22","doi-asserted-by":"crossref","unstructured":"Dayan SH, Jones DH, Carruthers J, et al. A pooled analysis of the safety and efficacy results of the multicenter, double-blind, randomized, placebo-controlled phase 3 REFINE-1 and REFINE-2 trials of ATX-101, a submental contouring injectable drug for the reduction of submental fat [abstract no. 25542]. In: American Society of Plastic Surgeons: Plastic Surgery The Meeting; 2014.","DOI":"10.1097\/01.prs.0000455489.32830.4a"},{"key":"231_CR23","unstructured":"Beer K, Donofrio L, Gross TM, et al. Clinically meaningful reduction in submental fat during and after treatment with ATX-101 in the US\/CAN phase 3 trials, REFINE-1 and REFINE-2 [oral presentation 1294]. In: American Academy of Dermatology Annual Meeting; 2015."},{"key":"231_CR24","unstructured":"Monheit GD, Humphrey S, Joseph JH, et al. Assessing the psychological and visual impact of submental fat using a validated questionnaire (Patient-Reported Submental Fat Impact Scale): result of a pooled analysis from the REFINE trials [abstract]. In: American Society for Dermatologic Surgery Annual Meeting; 2015."},{"key":"231_CR25","unstructured":"Brandt FS, Maas C, Lizzul PF, et al. Efficacy of ATX-101 for reducing submental fullness associated with submental fat in demographic subgroups of subjects from the US\/CAN phase 3 trials, REFINE-1 and REFINE-2 [oral presentation no. 1284]. In: American Academy of Dermatology Annual Meeting; 2015."},{"issue":"5","key":"231_CR26","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00266-014-0364-9","volume":"38","author":"J McDiarmid","year":"2014","unstructured":"McDiarmid J, Ruiz JB, Lee D, et al. Results from a pooled analysis of two European, randomized, placebo-controlled, phase 3 studies of ATX-101 for the pharmacologic reduction of excess submental fat. Aesthetic Plast Surg. 2014;38(5):849\u201360.","journal-title":"Aesthetic Plast Surg."},{"key":"231_CR27","unstructured":"Global Education Group and MedEdicus LLC. Achieving total facial rejuvenation with submental contouring: current and emerging strategies [CME Educational Session]. In: American Society for Dermatologic Surgery Annual Meeting; 2014."},{"issue":"4","key":"231_CR28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/MOO.0b013e328348c1cb","volume":"19","author":"N Dulguerov","year":"2011","unstructured":"Dulguerov N, D\u2019Souza A. Update on treatment rationale and options for the ageing face. Curr Opin Otolaryngol Head Neck Surg. 2011;19(4):269\u201375.","journal-title":"Curr Opin Otolaryngol Head Neck Surg."},{"key":"231_CR29","unstructured":"Beer K, Callender V, Fagien S, et al. The condition of submental fullness and treatment outcomes registry (CONTOUR): a non-interventional study of submental fullness, treatment options administered, and associated outcomes [abstract]. In: American Society for Dermatologic Surgery Annual Meeting; 2015."}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-016-0231-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40257-016-0231-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-016-0231-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T01:52:32Z","timestamp":1568512352000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40257-016-0231-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,26]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["231"],"URL":"https:\/\/doi.org\/10.1007\/s40257-016-0231-3","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,26]]}}}